Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 219
Filtrer
1.
Crit Rev Toxicol ; 39(6): 512-37, 2009.
Article de Anglais | MEDLINE | ID: mdl-19545199

RÉSUMÉ

To better understand the relevance of tunica vaginalis mesotheliomas (TVM) to human cancer risk, we examined the nature of TVM responses in 21 published rat cancer bioassays against the backdrop of the biology and molecular biology of mesothelium, and of spontaneous and treatment-induced TVM. Although relatively rare in all species including humans, TVM are seen most frequently in F344 male rats, as opposed to other rat strains, and are causally associated with the high background incidence of Leydig-cell tumors of the testes of these rats. Hormone imbalance brought about by perturbations of the endocrine system is proposed as a key factor leading to both spontaneous and treatment-associated TVM. Of 21 F344 rat studies with a treatment-associated TVM response, 7 were judged to have a nonsignificant to marginal response, 11 had a robust TVM response, and 3 were noninformative due to early mortality from other induced tumors. Of the 11 chemicals with robust responses, 8 were directly mutagenic in Salmonella and 3 are known to be mutagenic after metabolism. Only 2 of the 7 with nonsignificant to marginal responses were Ames test positive. TVM induction is a male F344 rat-specific event, and chemicals/agents that induce only TVM in the male F344 rat from a typical two-sex rat and mouse chronic bioassay are likely irrelevant in human risk assessment.


Sujet(s)
Mésothéliome/induit chimiquement , Tumeurs du testicule/induit chimiquement , Xénobiotique/toxicité , Animaux , Transformation cellulaire néoplasique/induit chimiquement , Transformation cellulaire néoplasique/effets des médicaments et des substances chimiques , Transformation cellulaire néoplasique/métabolisme , Humains , Mâle , Mésothéliome/mortalité , Mésothéliome/physiopathologie , Tests de mutagénicité , Rats , Appréciation des risques , Tumeurs du testicule/mortalité , Tumeurs du testicule/physiopathologie , Xénobiotique/métabolisme
2.
Toxicol Lett ; 132(3): 249-61, 2002 Jun 24.
Article de Anglais | MEDLINE | ID: mdl-12044706

RÉSUMÉ

Acrylonitrile, a high volume organic chemical, was tested for reproductive effects in a three generation drinking water study with two matings per generation. Sprague-Dawley rats were exposed to acrylonitrile in drinking water at 0, 100, or 500 ppm. This corresponds to 0, 11+/-5 and 37+/-10 mg/kg, respectively, for males and 0, 20+/-3 and 40+/-8 mg/kg per day for the females, respectively. Water consumption was reduced in F0 rats in the 100 and 500 ppm groups. At 500 ppm, acrylonitrile reduced body weight gain and food intake of the first generation parental rats (F0). These parameters were not investigated at subsequent generations. The pup survival (both viability and lactation indices) was reduced at the 500 ppm treatment level in both matings of all three generations. Fostering the 500 ppm pups onto untreated mothers following the second mating lessened mortality, suggesting a maternal effect consistent with decreased water consumption. There was no remarkable change in the reproductive capacity in any of matings in rats at the 100 ppm concentration. In contrast, in all three generations, the body weights of the pups of the 500 ppm treatment level were reduced on Day 21 at both matings. No adverse findings were observed in the tissues of a limited number of third generation weanlings (F3b) upon gross and microscopic evaluation. No effect on the sciatic nerve was evident among the adult female rats held for 20 weeks after weaning of the second litter. There was a dose-related effect of acrylonitrile on gross masses in female rats at each parental generation held 20 weeks after the weaning of the second litter. Histopathological evaluation of these dams showed an increase in astrocytomas and zymbal gland tumors.


Sujet(s)
Acrylonitrile/toxicité , Astrocytome/induit chimiquement , Cancérogènes/toxicité , Tumeurs de l'oreille/induit chimiquement , Reproduction/effets des médicaments et des substances chimiques , Acrylonitrile/administration et posologie , Administration par voie orale , Animaux , Astrocytome/anatomopathologie , Poids/effets des médicaments et des substances chimiques , Tests de cancérogénicité , Cancérogènes/administration et posologie , Relation dose-effet des médicaments , Consommation de boisson/effets des médicaments et des substances chimiques , Conduit auditif externe/anatomopathologie , Tumeurs de l'oreille/anatomopathologie , Consommation alimentaire/effets des médicaments et des substances chimiques , Femelle , Fécondité/effets des médicaments et des substances chimiques , Viabilité foetale/effets des médicaments et des substances chimiques , Lactation/effets des médicaments et des substances chimiques , Mâle , Rats , Rat Sprague-Dawley , Nerf ischiatique/cytologie , Nerf ischiatique/effets des médicaments et des substances chimiques , Taux de survie , Temps , Tests de toxicité
3.
J Neurosci ; 21(17): 6666-72, 2001 Sep 01.
Article de Anglais | MEDLINE | ID: mdl-11517256

RÉSUMÉ

Cerebellar Purkinje cells receive two distinctive types of excitatory inputs. Climbing fiber (CF) synapses have a high probability of release and show paired-pulse depression (PPD), whereas parallel fiber (PF) synapses facilitate and have a low probability of release. We examined both types of synapses using serial electron microscopic reconstructions in 15-d-old rats to look for anatomical correlates of these differences. PF and CF synapses were distinguishable by their overall ultrastructural organization. There were differences between PF and CF synapses in how many release sites were within 1 microm of a mitochondrion (67 vs 84%) and in the degree of astrocytic ensheathment (67 vs 94%). However, the postsynaptic density sizes for both types of synapses were similar (0.13-0.14 microm(2)). For both types of synapses, we counted the number of docked vesicles per release site to test whether this number determines the probability of release and synaptic plasticity. PF and CF synapses had the same number of anatomically docked vesicles (7-8). The number of docked vesicles at the CF does not support a simple model of PPD in which release of a single vesicle during the first pulse depletes the anatomically docked vesicle pool at a synapse. Alternatively, only a fraction of anatomically docked vesicles may be release ready, or PPD could result from multivesicular release at each site. Similarities in the number of docked vesicles for PF and CF synapses indicate that differences in probability of release are unrelated to the number of anatomically docked vesicles at these synapses.


Sujet(s)
Cervelet/ultrastructure , Cellules de Purkinje/ultrastructure , Synapses/ultrastructure , Animaux , Axones/ultrastructure , Structures de la membrane cellulaire/ultrastructure , Dendrites/ultrastructure , Microscopie électronique , Mitochondries/ultrastructure , Plasticité neuronale , Neurones afférents/ultrastructure , Rats , Rat Long-Evans , Vésicules synaptiques/ultrastructure
4.
Foot Ankle Int ; 22(3): 241-6, 2001 Mar.
Article de Anglais | MEDLINE | ID: mdl-11310867

RÉSUMÉ

Changes in the tibiotalar contact characteristics were investigated using eight fresh frozen cadaver ankle specimens to further develop an established model of the acquired flatfoot deformity. The deformity was simulated by sectioning the tendons and ligaments of the ankle and foot that normally support the longitudinal arch. Axial loads of 1,350 N were applied to the foot in a neutral position in both the intact specimen and flatfoot model. The flatfoot condition resulted in significant lateral shifts of 5.28 mm in global contact area and 11.26 mm in the location of peak pressure, and in a small but significant posterior shift of 1.14 mm in global contact area. The flatfoot condition also resulted in a significant, 35%, reduction in contact area. Significant increases in mean pressure, 14%, and peak pressure, 13%, were also found, but were not in proportion to the relatively large decrease in contact area. This suggests a transfer of load off of the talar dome. Increased loading of the lateral facet and fibula are suspected. The lateral shift in the contact region created a local increase in mean contact pressure that may be responsible for long term degenerative changes in patients with this deformity.


Sujet(s)
Articulation talocrurale/physiopathologie , Pied plat/physiopathologie , Anomalies morphologiques acquises du pied/physiopathologie , Modèles biologiques , Adulte , Phénomènes biomécaniques , Cadavre , Démarche/physiologie , Humains , Pression , Mise en charge
7.
Reprod Toxicol ; 14(5): 385-401, 2000.
Article de Anglais | MEDLINE | ID: mdl-11020651

RÉSUMÉ

Fischer 344 (F344) F(0) weanling rats, 30/sex/group, were exposed to acrylamide in drinking water at 0.0, 0.5, 2.0, or 5.0 mg/kg/day for 10 weeks and then mated. Exposure of F(0) females continued through gestation and lactation of F(1) litters. F(0) males, after F(0) mating, were removed from exposure and mated (one male: two untreated females) for the dominant lethal (DL) assay. Thirty F(l) weanlings/sex/group were exposed for 11 weeks to the same dose levels as their parents, and then mated to produce F(2) offspring. F(0) and F(l) parents and F(1) and F(2) weanlings were necropsied. Prebreeding exposure of F(0) and F(l) animals resulted in systemic toxicity at 2.0 to 5.0 mg/kg/day, with head tilt and/or foot splay increased at 0.5 to 5.0 mg/kg/day. F(0) and F(l) reproductive indices and gestational length were unaffected. Implantations and live pups/litter at birth were reduced at 5.0 mg/kg/day. Survival of F(l) and F(2) pups was reduced at 5.0 mg/kg/day for PND 0 through 4 only. In the DL assay, total and live implants were reduced, pre- and postimplantation loss was increased, and the frequency of DL factors (F(L)%) was increased at 5.0 mg/kg/day. At 5.0 mg/kg/day, adult F(l) male peripheral nerves exhibited axonal fragmentation and/or swelling; F(l) female spinal cord sections were unremarkable. The NOEL for prenatal DL was 2.0 mg/kg/day; the NOEL for adult systemic toxicity, including neurotoxicity, was < or = 0.5 mg/kg/day. Therefore, neurotoxicity and DL were differentially affected.


Sujet(s)
Acrylamide/effets indésirables , Gènes dominants/effets des médicaments et des substances chimiques , Gènes létaux/effets des médicaments et des substances chimiques , Reproduction/effets des médicaments et des substances chimiques , Alimentation en eau/analyse , Acrylamide/toxicité , Animaux , Poids/effets des médicaments et des substances chimiques , Femelle , Mâle , Grossesse , Rats , Rats de lignée F344 , Reproduction/génétique , Analyse de survie , États-Unis , Environmental Protection Agency (USA)
8.
J Consult Clin Psychol ; 68(4): 641-9, 2000 Aug.
Article de Anglais | MEDLINE | ID: mdl-10965639

RÉSUMÉ

Individuals with binge eating disorder (BED) have high rates of comorbid psychopathology, yet little is known about the relation of comorbidity to eating disorder features or response to treatment. These issues were examined among 162 BED patients participating in a psychotherapy trial. Axis I psychopathology was not significantly related to baseline eating disorder severity, as measured by the Structured Clinical Interview for DSM-III-R (SCID-I and SCID-II) and the Eating Disorder Examination. However, presence of Axis II psychopathology was significantly related to more severe binge eating and eating disorder psychopathology at baseline. Although overall presence of Axis II psychopathology did not predict treatment outcome, presence of Cluster B personality disorders predicted significantly higher levels of binge eating at 1 year following treatment. Results suggest the need to consider Cluster B disorders when designing treatments for BED.


Sujet(s)
Boulimie/épidémiologie , Boulimie/thérapie , Troubles de la personnalité/épidémiologie , Psychothérapie/méthodes , Adulte , Indice de masse corporelle , Boulimie/prévention et contrôle , Comorbidité , Femelle , Humains , Mâle , Troubles mentaux/diagnostic , Troubles mentaux/épidémiologie , Adulte d'âge moyen , Troubles de la personnalité/diagnostic , Échelles d'évaluation en psychiatrie , Facteurs de risque , Prévention secondaire , Indice de gravité de la maladie , Résultat thérapeutique , États-Unis/épidémiologie
9.
J Neurosci ; 20(12): 4414-22, 2000 Jun 15.
Article de Anglais | MEDLINE | ID: mdl-10844010

RÉSUMÉ

Strontium is capable of supporting synaptic transmission, but release is dramatically different from that evoked in calcium. By measuring presynaptic strontium levels, we gain insight into the actions of strontium, which has implications for the identification of molecules involved in different aspects of synaptic transmission. We examined presynaptic divalent levels and synaptic release at the granule cell to stellate cell synapse in mouse cerebellar slices. We find that the prolonged duration of release and paired-pulse facilitation in the presence of strontium can be accounted for by the slower removal of strontium from the presynaptic terminal. Phasic and delayed release are both driven by strontium less effectively than by calcium, indicating that a heightened sensitivity to strontium is not a feature of the binding sites involved in facilitation and delayed release. We also find that the cooperativity for phasic release is 1.7 for strontium compared with 3.2 for calcium, suggesting that differential binding may help to identify the calcium sensor involved in phasic release.


Sujet(s)
Cervelet/physiologie , Neurones/physiologie , Strontium/pharmacocinétique , Transmission synaptique/physiologie , Animaux , Bicuculline/pharmacologie , Calcium/métabolisme , Cervelet/effets des médicaments et des substances chimiques , Potentiels évoqués/effets des médicaments et des substances chimiques , Potentiels évoqués/physiologie , Techniques in vitro , Cinétique , Souris , Souris de lignée ICR , Neurones/effets des médicaments et des substances chimiques , Transmission synaptique/effets des médicaments et des substances chimiques
10.
Reprod Toxicol ; 14(2): 147-57, 2000.
Article de Anglais | MEDLINE | ID: mdl-10825678

RÉSUMÉ

To determine whether there is a relationship between the reproductive and neurotoxic effects of acrylamide monomer (AM), the first week of the study design of Sublet et al. ¿14 was duplicated: Long-Evans male rats were gavaged with AM in water, 25/group, at 0, 5, 15, 30, 45, or 60 mg/kg/day for 5 days (days 1 through 5). On Day 8, males were paired overnight with untreated virgin females (1 : 1) in proestrus/estrus. On day 9, males were evaluated for forelimb and hindlimb grip strength. Five males/group were perfusion fixed, 20/group were used for andrologic assessment, and all were necropsied. Perfusion-fixed sciatic nerves were examined histologically. Sperm-positive females were examined for preimplantation and postimplantation loss at midpregnancy. At 15 to 60 mg/kg/day, males exhibited significantly reduced weight gain, reduced mating, fertility, and pregnancy indices by trend analysis (significant at 60 mg/kg/d by pairwise comparison), and increased postimplantation loss and dominant lethal factor, F(L)%, at 45 and 60 mg/kg/day. At 60 mg/kg/day, the sperm beat cross frequency was increased, with no significant effects on epididymal sperm motility or concentration, and hindlimb grip strength was decreased, with no pathologic lesions in sciatic nerves. Therefore, epididymal sperm, mating, and neurotoxic effects were observed at AM doses that also resulted in increased postimplantation loss, possibly by different mechanisms.


Sujet(s)
Acrylamide/toxicité , Encéphale/effets des médicaments et des substances chimiques , Reproduction/effets des médicaments et des substances chimiques , Animaux , Poids/effets des médicaments et des substances chimiques , Implantation embryonnaire/effets des médicaments et des substances chimiques , Femelle , Membre thoracique/effets des médicaments et des substances chimiques , Membre thoracique/physiologie , Gènes létaux/effets des médicaments et des substances chimiques , Force de la main/physiologie , Membre pelvien/effets des médicaments et des substances chimiques , Membre pelvien/physiologie , Infertilité masculine/induit chimiquement , Mâle , Maladies du système nerveux/induit chimiquement , Grossesse , Rats , Rat Long-Evans , Nerf ischiatique/anatomopathologie , Mobilité des spermatozoïdes/effets des médicaments et des substances chimiques
11.
Brain Res ; 852(2): 297-304, 2000 Jan 10.
Article de Anglais | MEDLINE | ID: mdl-10678756

RÉSUMÉ

Using the rat pheochromocytoma cell line (PC12), we present molecular evidence that the neurotoxicant acrylamide directly induces neurofilament gene expression, and the signaling pathways are initially distinctive from, but eventually merged into, that for nerve growth factor (NGF)-induced neurofilament expression. In PC12 cells, acrylamide increased neurofilament protein levels and synthesis. Acrylamide had no effect on the stability of neurofilament mRNAs suggesting that it directly increased neurofilament mRNA synthesis. K252a, a selective inhibitor for NGF receptor gp140trk, had no effect on acrylamide induction, but completely inhibited NGF-induced neurofilament protein synthesis. Therefore, the initial step for acrylamide signaling was distinctive from NGF. Dexamethasone reversed the effects of both NGF and acrylamide on neurofilament protein levels and synthesis indicated that there is a dexamethasone-sensitive signaling step upon which NGF and acrylamide merge, suggesting involvement of transcription-activating proteins like AP-1. These results, taken together with previous studies of transgenic mice that overexpress neurofilament genes, may partially explain the mechanisms of neurofilament accumulation in distal parts of large axons, a pathognomonic feature of acrylamide neurotoxicity in animals.


Sujet(s)
Acrylamide/pharmacologie , Protéines neurofilamenteuses/génétique , Neurones/effets des médicaments et des substances chimiques , Animaux , Technique de Western , Dexaméthasone/pharmacologie , Expression des gènes/effets des médicaments et des substances chimiques , Glucocorticoïdes/pharmacologie , Facteurs de croissance nerveuse/pharmacologie , Protéines neurofilamenteuses/analyse , Neurones/cytologie , Neurones/physiologie , Neurotoxines/pharmacologie , Cellules PC12 , ARN messager/analyse , Rats , Récepteur trkA/analyse , Récepteur trkA/génétique , Ribonucléases , Transduction du signal/effets des médicaments et des substances chimiques
12.
Mutagenesis ; 15(2): 133-6, 2000 Mar.
Article de Anglais | MEDLINE | ID: mdl-10719038

RÉSUMÉ

Acrylamide (AA) is a germ cell mutagen and induces clastogenic effects predominantly in spermatids of mice. The mechanism of AA clastogenicity has been a matter of dispute. Since the reactivity of AA with DNA is low but is high with proteins containing SH groups, it was suggested that protamine alkylation could be the mechansim of clastogenicity by AA in spermatids. This was substantiated by the observation that the time course of protamine alkylation and dominant lethal effects in spermatids of mice induced by AA was strictly parallel. Another suggestion was that AA may be metabolized by cytochrome P-450 to the epoxide glycidamide (GA), which is then the ultimate DNA-reactive clastogen. This suggestion was based on the similarity of the stage specificity pattern for dominant lethality and heritable translocation induction by AA and GA. To test this latter assumption, 1-aminobenzotriazole (ABT), an inhibitor of P-450 metabolism, was used in the present experiments. Male mice were pretreated with ABT (3x50 mg/kg) on three consecutive days followed by AA treatment (125 mg/kg) on day 4. Parallel groups of animals were treated with AA (125 mg/kg), ABT (3x50 mg/kg) or with the solvent double-distilled water. The experiment was repeated once with slightly varied mating parameters. The results of both experiments showed that ABT inhibited or significantly reduced the AA-induced dominant lethal effects. Thus, the present data support the hypothesis that the AA metabolite GA is the ultimate clastogen in mouse spermatids.


Sujet(s)
Acrylamide/toxicité , Antimutagènes/pharmacologie , Gènes dominants , Gènes létaux , Mutagènes/toxicité , Spermatides/effets des médicaments et des substances chimiques , Triazoles/pharmacologie , Animaux , Composés époxy/métabolisme , Femelle , Fécondité/effets des médicaments et des substances chimiques , Mâle , Souris , Mobilité des spermatozoïdes/effets des médicaments et des substances chimiques
13.
Reprod Toxicol ; 13(6): 511-20, 1999.
Article de Anglais | MEDLINE | ID: mdl-10613399

RÉSUMÉ

We duplicated the study design of Husain et al. (Ind Health 1987; 25:19-28) to determine whether maternal exposure to acrylamide monomer (AM) resulted in offspring neurotoxicity. Wistar rat dams with litters (15/group) were gavaged with AM in saline at 0 or 25.0 mg/kg/d throughout lactation (pnd 0-21). Maternal feed and water consumption, body weights (BW), and Functional Observational Battery (FOB) were recorded. At weaning (pnd 21), maternal sciatic nerves were examined histologically. Male offspring were retained until pnd 91, with BW and grip strength evaluations. Dosed dams exhibited progressive toxicity, including mortality (two), severely reduced feed and water consumption, BW, and BW gain, and behavioral neurotoxicity (with no sciatic nerve pathology). Nursing offspring at 25.0 mg/kg/d exhibited increased mortality and reduced BW associated with little/no milk in stomachs. Postwean males at 25.0 mg/kg/d exhibited normal BW gain and increasing grip strength over time. Therefore, AM caused maternal toxicity; offspring effects during lactation were consistent with inanition from maternal toxicity. Postwean males exhibited recovery with no signs of AM-mediated toxicity. These results do not support the conclusions of Husain et al.


Sujet(s)
Acrylamide/toxicité , Animaux allaités , Lactation , Administration par voie orale , Animaux , Poids/effets des médicaments et des substances chimiques , Comportement dipsique/effets des médicaments et des substances chimiques , Comportement alimentaire/effets des médicaments et des substances chimiques , Femelle , Lactation/effets des médicaments et des substances chimiques , Mâle , Activité motrice/effets des médicaments et des substances chimiques , Rats , Rat Wistar
14.
Toxicol Sci ; 52(1): 107-21, 1999 Nov.
Article de Anglais | MEDLINE | ID: mdl-10568704

RÉSUMÉ

Modulation of endocrine function is frequently a confounding factor in the interpretation of chronic rodent toxicology studies. Of particular interest are agents that cause deviation of thyroid hormone homeostasis and result in thyroid cancer for rodents. An endocrine challenge test (ECT), commonly used to study endocrine organ health in human and veterinary medicine, quantifies the response of the thyroid to tropic hormones. This study compared the response of Fischer (F344) and Sprague-Dawley (SD) rats to a thyrotropin-releasing hormone (TRH) ECT and a thyroid-stimulating hormone (TSH) ECT and characterized the dose-response curve. TSH, thyroxine (T4), triiodothyronine (T3), and prolactin responses were characterized for several doses of TRH over a 4-h time period. Animals were equipped with intra-atrial cannulae and were free moving at all times during blood sampling. Both strains of rats responded to intravenous TRH by releasing TSH into their blood in a dose-responsive fashion. At doses of > or = 100 ng, TSH concentrations were increased by more than 2-fold at 2 min. Concentrations reached a maximum at 15 min for doses of 100 ng/100 g body weight (bw) to 5000 ng/100g bw. The effective dose 50 (ED50) of TRH (that dose causing release of half maximal TSH concentrations) was 61 ng in F344 rats and 78 ng in SD rats. The ED75 was 173 ng and 217 ng/100 g bw, respectively. The response of T4 and T3 after TRH ECT and TSH ECT was highly variable. F344 rats responded with an increase in levels of both hormones, starting at 60 min and continuing through 240 min. In SD rats, the presence of a thyroid hormone response (T4) was present, although that of T3 was not clear. These data provide essential information for design of toxicology studies focused on the effects of toxicants and drugs on the pituitary-thyroid axis.


Sujet(s)
Hypophyse/effets des médicaments et des substances chimiques , Prolactine/pharmacologie , Glande thyroide/effets des médicaments et des substances chimiques , Hormones thyroïdiennes/pharmacologie , Animaux , Relation dose-effet des médicaments , Mâle , Rats , Rats de lignée F344 , Rat Sprague-Dawley , Débit sécrétoire/effets des médicaments et des substances chimiques , Hormone de libération de la thyréostimuline/pharmacologie , Thyroxine/pharmacologie , Tri-iodothyronine/pharmacologie
15.
Int J Eat Disord ; 26(1): 81-5, 1999 Jul.
Article de Anglais | MEDLINE | ID: mdl-10349587

RÉSUMÉ

OBJECTIVE: This study examined whether married individuals have comparable body image disturbance to nonmarried individuals and whether the quality of a marital relationship is significantly related to body image disturbance in a sample of dieters. METHOD: Measures of marital status, marital satisfaction, and body dissatisfaction were administered to a sample of 16,377 subjects who had tried to lose weight at least once within the previous 3 years. RESULTS: Marital status was not associated with increased body dissatisfaction. Marital satisfaction was significantly related to body dissatisfaction when controlling for age, body mass index, self-esteem, and gender. DISCUSSION: Body dissatisfaction occurs at comparable levels among married and single individuals and the study of marital functioning among eating-disordered individuals represents a large gap in the literature.


Sujet(s)
Image du corps , Mariage/psychologie , Satisfaction personnelle , Troubles somatoformes/diagnostic , Troubles somatoformes/psychologie , Adulte , Indice de masse corporelle , Femelle , Humains , Mâle , Concept du soi
16.
Cancer Chemother Pharmacol ; 43 Suppl: S100-3, 1999.
Article de Anglais | MEDLINE | ID: mdl-10357567

RÉSUMÉ

This article outlines some of the complexities and challenges confronting researchers and the US Food and Drug Administration (FDA) in the area of evaluation of antimetastatic and other novel anticancer therapies. The scientific regulatory matrix utilized by the FDA is outlined. Subsequently, the complications encountered when designing and interpreting studies of antimetastatic drugs are described, and finally changes in the regulatory landscape both within the USA and internationally are considered.


Sujet(s)
Antinéoplasiques/usage thérapeutique , Évaluation de médicament/législation et jurisprudence , Métastase tumorale/traitement médicamenteux , Métastase tumorale/prévention et contrôle , États-Unis , Food and Drug Administration (USA)
17.
JAMA ; 281(18): 1728-34, 1999 May 12.
Article de Anglais | MEDLINE | ID: mdl-10328074

RÉSUMÉ

The removal of 5 pharmaceuticals from the market in a 12-month period because of unexpected adverse events raised concerns about the adequacy of the drug review process at the US Food and Drug Administration (FDA). Specifically, concerns were raised about improvements in drug review efficiency that significantly reduced FDA review times. We have reviewed the circumstances of the 5 removals to determine whether there was any relationship to the increased efficiencies in the drug review process. When the removed drugs were analyzed by date of approval, no increase in the number of drugs taken off the market was seen, demonstrating that reduced review processing time was not the reason for the cluster of removals. We conclude that the agency's drug review procedures and postmarketing surveillance system after a drug has been marketed are currently adequate but must continually adjust to future challenges.


Sujet(s)
Agrément de médicaments , Contrôle des médicaments et des stupéfiants , Surveillance post-commercialisation des produits de santé , Food and Drug Administration (USA) , Systèmes de signalement des effets indésirables des médicaments , Antiallergiques , Anti-inflammatoires non stéroïdiens , Anorexigènes , Benzimidazoles , Benzophénones , Bromobenzènes , Inhibiteurs des canaux calciques , Dexfenfluramine , Fenfluramine , Terfénadine , 1,2,3,4-Tétrahydro-naphtalènes , États-Unis
18.
Toxicol Sci ; 47(2): 151-7, 1999 Feb.
Article de Anglais | MEDLINE | ID: mdl-10220851

RÉSUMÉ

High exposure to the acrylamide monomer has been associated with neuropathy and neurotoxic effects. Chronic lower exposure causes endocrine disruption associated with thyroid, testicular, and mammary tumors. To investigate mechanisms of endocrine disruption, short-term, low-level oral dosing studies were conducted. Weanling female Fischer 344 rats were acclimatized for two weeks before dosing. Controls were given distilled water by gavage and rats in other groups were given acrylamide at doses of 2 mg/kg/day and 15 mg/kg/day for 2 or 7 days by gavage. Twenty-four h after the last dose, the rats were killed by decapitation. Trunk blood was collected for hormone analyses and tissues for histopathological examination. There were no toxicity-related deaths, no clinical signs of toxicity, and no significant difference in the mean body weight of animal groups. Histopathological examination of select tissues showed no lesions of pathologic significance. Plasma thyroxine (T4), thyroid stimulating hormone (TSH), prolactin (PRL), and pituitary TSH and PRL analyses did not reveal significant changes between control vs. treated rats. In the 7-day study, however, there was a slight dose-dependent increase in plasma T4 and a slight dose-dependent decrease in plasma TSH. Thyroid gland morphometry showed a significant (p < 0.05) decrease in the colloid area and a significant increase (p < 0.05) in the follicular cell height of treated rats as compared to controls. The follicular area shrinkage was similar in both studies. These results show a very early endocrine response to very low levels of toxic insult and opens other venues to further investigate the mechanisms of endocrine disruption by acrylamide.


Sujet(s)
Acrylamide/toxicité , Glande thyroide/effets des médicaments et des substances chimiques , Analyse de variance , Animaux , Femelle , Homéostasie/effets des médicaments et des substances chimiques , Taille d'organe/effets des médicaments et des substances chimiques , Hypophyse/effets des médicaments et des substances chimiques , Rats , Rats de lignée F344 , Glande thyroide/anatomopathologie , Tests de toxicité
19.
Biophys J ; 76(4): 2029-42, 1999 Apr.
Article de Anglais | MEDLINE | ID: mdl-10096899

RÉSUMÉ

Strontium can replace calcium in triggering neurotransmitter release, although peak release is reduced and the duration of release is prolonged. Strontium has therefore become useful in probing release, but its mechanism of action is not well understood. Here we study the action of strontium at the granule cell to Purkinje cell synapse in mouse cerebellar slices. Presynaptic residual strontium levels were monitored with fluorescent indicators, which all responded to strontium (fura-2, calcium orange, fura-2FF, magnesium green, and mag-fura-5). When calcium was replaced by equimolar concentrations of strontium in the external bath, strontium and calcium both entered presynaptic terminals. Contaminating calcium was eliminated by including EGTA in the extracellular bath, or by loading parallel fibers with EGTA, enabling the actions of strontium to be studied in isolation. After a single stimulus, strontium reached higher peak free levels than did calcium (approximately 1.7 times greater), and decayed more slowly (half-decay time 189 ms for strontium and 32 ms for calcium). These differences in calcium and strontium dynamics are likely a consequence of greater strontium permeability through calcium channels, lower affinity of the endogenous buffer for strontium, and less efficient extrusion of strontium. Measurements of presynaptic divalent levels help to explain properties of release evoked by strontium. Parallel fiber synaptic currents triggered by strontium are smaller in amplitude and longer in duration than those triggered by calcium. In both calcium and strontium, release consists of two components, one more steeply dependent on divalent levels than the other. Strontium drives both components less effectively than does calcium, suggesting that the affinities of the sensors involved in both phases of release are lower for strontium than for calcium. Thus, the larger and slower strontium transients account for the prominent slow component of release triggered by strontium.


Sujet(s)
Terminaisons présynaptiques/effets des médicaments et des substances chimiques , Terminaisons présynaptiques/physiologie , Strontium/pharmacologie , Transmission synaptique/effets des médicaments et des substances chimiques , Transmission synaptique/physiologie , Animaux , Phénomènes biophysiques , Biophysique , Calcium/métabolisme , Calcium/pharmacologie , Signalisation calcique , Chélateurs/pharmacologie , Acide egtazique/pharmacologie , Colorants fluorescents , Fura-2 , Techniques in vitro , Cinétique , Souris , Souris de lignée ICR , Modèles neurologiques , Agents neuromédiateurs/métabolisme , Cellules de Purkinje/effets des médicaments et des substances chimiques , Cellules de Purkinje/métabolisme , Cellules de Purkinje/physiologie , Transduction du signal
20.
Neural Comput ; 11(1): 1-20, 1999 Jan 01.
Article de Anglais | MEDLINE | ID: mdl-9950719

RÉSUMÉ

The auditory and electrosensory systems contain circuits that are specialized for the encoding and processing of microsecond time differences. Analysis of these circuits in two specialists, weakly electric fish and barn owls, has uncovered common design principles and illuminated some aspects of their evolution.


Sujet(s)
Voies auditives/physiologie , Organe électrique/innervation , Temps , Algorithmes , Animaux , Poulets/physiologie , Poisson électrique/physiologie , Voies nerveuses/physiologie , Strigiformes/physiologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE